Skip to main content
. 2017 Dec 8;10:728. doi: 10.1186/s13104-017-3070-2

Table 1.

Characteristics of the ambulatory older patients and comparisons between patients who were prescribed cold combination products and patients who were not

Total, N = 756 Cold combination products during 1-year follow-up p-valuea
Yes, N = 46 No, N = 710
Age, mean ± SD 75.3 ± 7.3 76.1 ± 7.2 75.3 ± 7.3 0.48
Men, n (%) 392 (51.9) 19 (41.3) 373 (52.5) 0.14
Women, n (%) 364 (48.1) 27 (58.7) 337 (47.5) 0.14
Total exemption from co-payment, n (%) 59 (7.8) 7 (15.2) 52 (7.3) 0.05
Charlson Comorbidity Index, mean ± SD 1.8 ± 1.6 1.8 ± 1.6 1.8 ± 1.6 0.93
Number of medications
 Total, mean ± SD 4.8 ± 2.9 7.0 ± 3.5 4.7 ± 2.7 < 0.001
 No medication, n (%) 21 (2.8) 1 (2.2) 20 (2.8) 1.00
 1–4 medications, n (%) 362 (47.9) 11 (23.9) 351 (49.4) < 0.001
 5–9 medications, n (%) 319 (42.2) 23 (50.0) 296 (41.7) 0.27
 10 or more medications, n (%) 54 (7.1) 11 (23.9) 43 (6.1) < 0.001
Past medical history, n (%)
 Dementia 41 (5.4) 2 (4.3) 39 (5.5) 0.74
 Ischemic stroke 96 (12.7) 5 (10.9) 91 (12.8) 0.82
 Myocardial infarction 40 (5.3) 4 (8.7) 36 (5.1) 0.29
 Diabetes mellitus 251 (33.2) 12 (26.1) 239 (33.7) 0.29
 Chronic kidney disease 248 (32.8) 20 (43.5) 228 (32.1) 0.11
 Peptic ulcer 155 (20.5) 5 (10.9) 150 (21.1) 0.09
Frequency of prescription with cold combination products
 Once 26 (56.5)
 Two or three times 10 (21.7)
 Four or more times 10 (21.7)

aChi squared tests were used for comparisons between patients who were prescribed cold combination products and patients who were not

HHS Vulnerability Disclosure